Cargando…
Evaluation of a bone filler scaffold for local antibiotic delivery to prevent Staphylococcus aureus infection in a contaminated bone defect
We previously reported the development of an osteogenic bone filler scaffold consisting of degradable polyurethane, hydroxyapatite, and decellularized bovine bone particles. The current study was aimed at evaluating the use of this scaffold as a means of local antibiotic delivery to prevent infectio...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119729/ https://www.ncbi.nlm.nih.gov/pubmed/33986462 http://dx.doi.org/10.1038/s41598-021-89830-z |
_version_ | 1783691914784014336 |
---|---|
author | Beenken, Karen E. Campbell, Mara J. Ramirez, Aura M. Alghazali, Karrar Walker, Christopher M. Jackson, Bailey Griffin, Christopher King, William Bourdo, Shawn E. Rifkin, Rebecca Hecht, Silke Meeker, Daniel G. Anderson, David E. Biris, Alexandru S. Smeltzer, Mark S. |
author_facet | Beenken, Karen E. Campbell, Mara J. Ramirez, Aura M. Alghazali, Karrar Walker, Christopher M. Jackson, Bailey Griffin, Christopher King, William Bourdo, Shawn E. Rifkin, Rebecca Hecht, Silke Meeker, Daniel G. Anderson, David E. Biris, Alexandru S. Smeltzer, Mark S. |
author_sort | Beenken, Karen E. |
collection | PubMed |
description | We previously reported the development of an osteogenic bone filler scaffold consisting of degradable polyurethane, hydroxyapatite, and decellularized bovine bone particles. The current study was aimed at evaluating the use of this scaffold as a means of local antibiotic delivery to prevent infection in a bone defect contaminated with Staphylococcus aureus. We evaluated two scaffold formulations with the same component ratios but differing overall porosity and surface area. Studies with vancomycin, daptomycin, and gentamicin confirmed that antibiotic uptake was concentration dependent and that increased porosity correlated with increased uptake and prolonged antibiotic release. We also demonstrate that vancomycin can be passively loaded into either formulation in sufficient concentration to prevent infection in a rabbit model of a contaminated segmental bone defect. Moreover, even in those few cases in which complete eradication was not achieved, the number of viable bacteria in the bone was significantly reduced by treatment and there was no radiographic evidence of osteomyelitis. Radiographs and microcomputed tomography (µCT) analysis from the in vivo studies also suggested that the addition of vancomycin did not have any significant effect on the scaffold itself. These results demonstrate the potential utility of our bone regeneration scaffold for local antibiotic delivery to prevent infection in contaminated bone defects. |
format | Online Article Text |
id | pubmed-8119729 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-81197292021-05-17 Evaluation of a bone filler scaffold for local antibiotic delivery to prevent Staphylococcus aureus infection in a contaminated bone defect Beenken, Karen E. Campbell, Mara J. Ramirez, Aura M. Alghazali, Karrar Walker, Christopher M. Jackson, Bailey Griffin, Christopher King, William Bourdo, Shawn E. Rifkin, Rebecca Hecht, Silke Meeker, Daniel G. Anderson, David E. Biris, Alexandru S. Smeltzer, Mark S. Sci Rep Article We previously reported the development of an osteogenic bone filler scaffold consisting of degradable polyurethane, hydroxyapatite, and decellularized bovine bone particles. The current study was aimed at evaluating the use of this scaffold as a means of local antibiotic delivery to prevent infection in a bone defect contaminated with Staphylococcus aureus. We evaluated two scaffold formulations with the same component ratios but differing overall porosity and surface area. Studies with vancomycin, daptomycin, and gentamicin confirmed that antibiotic uptake was concentration dependent and that increased porosity correlated with increased uptake and prolonged antibiotic release. We also demonstrate that vancomycin can be passively loaded into either formulation in sufficient concentration to prevent infection in a rabbit model of a contaminated segmental bone defect. Moreover, even in those few cases in which complete eradication was not achieved, the number of viable bacteria in the bone was significantly reduced by treatment and there was no radiographic evidence of osteomyelitis. Radiographs and microcomputed tomography (µCT) analysis from the in vivo studies also suggested that the addition of vancomycin did not have any significant effect on the scaffold itself. These results demonstrate the potential utility of our bone regeneration scaffold for local antibiotic delivery to prevent infection in contaminated bone defects. Nature Publishing Group UK 2021-05-13 /pmc/articles/PMC8119729/ /pubmed/33986462 http://dx.doi.org/10.1038/s41598-021-89830-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Beenken, Karen E. Campbell, Mara J. Ramirez, Aura M. Alghazali, Karrar Walker, Christopher M. Jackson, Bailey Griffin, Christopher King, William Bourdo, Shawn E. Rifkin, Rebecca Hecht, Silke Meeker, Daniel G. Anderson, David E. Biris, Alexandru S. Smeltzer, Mark S. Evaluation of a bone filler scaffold for local antibiotic delivery to prevent Staphylococcus aureus infection in a contaminated bone defect |
title | Evaluation of a bone filler scaffold for local antibiotic delivery to prevent Staphylococcus aureus infection in a contaminated bone defect |
title_full | Evaluation of a bone filler scaffold for local antibiotic delivery to prevent Staphylococcus aureus infection in a contaminated bone defect |
title_fullStr | Evaluation of a bone filler scaffold for local antibiotic delivery to prevent Staphylococcus aureus infection in a contaminated bone defect |
title_full_unstemmed | Evaluation of a bone filler scaffold for local antibiotic delivery to prevent Staphylococcus aureus infection in a contaminated bone defect |
title_short | Evaluation of a bone filler scaffold for local antibiotic delivery to prevent Staphylococcus aureus infection in a contaminated bone defect |
title_sort | evaluation of a bone filler scaffold for local antibiotic delivery to prevent staphylococcus aureus infection in a contaminated bone defect |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119729/ https://www.ncbi.nlm.nih.gov/pubmed/33986462 http://dx.doi.org/10.1038/s41598-021-89830-z |
work_keys_str_mv | AT beenkenkarene evaluationofabonefillerscaffoldforlocalantibioticdeliverytopreventstaphylococcusaureusinfectioninacontaminatedbonedefect AT campbellmaraj evaluationofabonefillerscaffoldforlocalantibioticdeliverytopreventstaphylococcusaureusinfectioninacontaminatedbonedefect AT ramirezauram evaluationofabonefillerscaffoldforlocalantibioticdeliverytopreventstaphylococcusaureusinfectioninacontaminatedbonedefect AT alghazalikarrar evaluationofabonefillerscaffoldforlocalantibioticdeliverytopreventstaphylococcusaureusinfectioninacontaminatedbonedefect AT walkerchristopherm evaluationofabonefillerscaffoldforlocalantibioticdeliverytopreventstaphylococcusaureusinfectioninacontaminatedbonedefect AT jacksonbailey evaluationofabonefillerscaffoldforlocalantibioticdeliverytopreventstaphylococcusaureusinfectioninacontaminatedbonedefect AT griffinchristopher evaluationofabonefillerscaffoldforlocalantibioticdeliverytopreventstaphylococcusaureusinfectioninacontaminatedbonedefect AT kingwilliam evaluationofabonefillerscaffoldforlocalantibioticdeliverytopreventstaphylococcusaureusinfectioninacontaminatedbonedefect AT bourdoshawne evaluationofabonefillerscaffoldforlocalantibioticdeliverytopreventstaphylococcusaureusinfectioninacontaminatedbonedefect AT rifkinrebecca evaluationofabonefillerscaffoldforlocalantibioticdeliverytopreventstaphylococcusaureusinfectioninacontaminatedbonedefect AT hechtsilke evaluationofabonefillerscaffoldforlocalantibioticdeliverytopreventstaphylococcusaureusinfectioninacontaminatedbonedefect AT meekerdanielg evaluationofabonefillerscaffoldforlocalantibioticdeliverytopreventstaphylococcusaureusinfectioninacontaminatedbonedefect AT andersondavide evaluationofabonefillerscaffoldforlocalantibioticdeliverytopreventstaphylococcusaureusinfectioninacontaminatedbonedefect AT birisalexandrus evaluationofabonefillerscaffoldforlocalantibioticdeliverytopreventstaphylococcusaureusinfectioninacontaminatedbonedefect AT smeltzermarks evaluationofabonefillerscaffoldforlocalantibioticdeliverytopreventstaphylococcusaureusinfectioninacontaminatedbonedefect |